Evaxion Biotech A/S

NASDAQ: EVAX- / - / -
6.69-1.03-13.34%Vol 97.52K1Y Perf -31.53%
Apr 16th, 2021 11:10 DELAYED
BID6.65 ASK6.69
Open7.54 Previous Close7.72
Pre-Market- After-Market-
 - -%  - -
Target Price
20.50 
Analyst Rating
— — 0.00
Potential %
205.97 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap128.44M 
Earnings Rating
Price Range Ratio 52W %
29.54 
Earnings Date
-

Today's Price Range

6.607.62

52W Range

5.1610.34

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
26.77%
1 Month
1.71%
3 Months
-
6 Months
-
1 Year
-31.53%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
EVAX6.69-1.0300-13.34
AAPL134.03-0.4700-0.35
GOOG2 294.91-1.7500-0.08
MSFT259.560.06000.02
XOM56.96-0.0200-0.04
WFC43.190.95002.25
JNJ161.020.63000.39
FB306.38-1.4400-0.47
GE13.45-0.1000-0.74
JPM153.401.23000.81
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume97.52K
Shares Outstanding19.20M
Trades Count420
Dollar Volume714.65K
Avg. Volume116.93K
Avg. Weekly Volume116.51K
Avg. Monthly Volume119.63K
Avg. Quarterly Volume116.93K

Evaxion Biotech A/S (NASDAQ: EVAX) stock closed at 7.72 per share at the end of the most recent trading day (a 5.32% change compared to the prior day closing price) with a volume of 123.56K shares and market capitalization of 128.44M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the industry, sector and employs 0 people. Evaxion Biotech A/S CEO is .

The one-year performance of Evaxion Biotech A/S stock is -31.53%, while year-to-date (YTD) performance is %. EVAX stock has a five-year performance of %. Its 52-week range is between 5.16 and 10.34, which gives EVAX stock a 52-week price range ratio of 29.54%

Evaxion Biotech A/S currently has a PE ratio of -7.00, a price-to-book (PB) ratio of 15.09, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -130.31%, a ROC of -179.77% and a ROE of -183.15%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Evaxion Biotech A/S, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Evaxion Biotech A/S’s next earnings report date is -.

The consensus rating of Wall Street analysts for Evaxion Biotech A/S is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Evaxion Biotech A/S stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Evaxion Biotech A/S has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Evaxion Biotech A/S has a Neutral technical analysis rating based on Technical Indicators (ADX : 22.00, ATR14 : 0.35, CCI20 : 107.75, Chaikin Money Flow : -0.08, MACD : -0.12, Money Flow Index : 69.59, ROC : 42.96, RSI : 54.33, STOCH (14,3) : 91.46, STOCH RSI : 1.00, UO : 58.34, Williams %R : -8.54), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Evaxion Biotech A/S in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Evaxion Biotech A/S

CEO:

Telephone:

Address: , , ,

Number of employees: 0

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

67%33%

Bearish Bullish

67%33%

News

Stocktwits